Drugs / MU-11-1F4 124I
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00807872 | Dec 2008 → Mar 2012 | AL amyloidosis | University of Tennessee | Completed | No outcome recorded |
| Phase 1 | NCT01409148 | Nov 2008 → Mar 2012 | AL amyloidosis | University of Tennessee | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MU-11-1F4 124I | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109302 ↗ |
| Known as | Mu 11-1F4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01409148 ↗ |
| Modality | Monoclonal antibody | “radiolabeled amyloid-reactive monoclonal antibody” NCT00807872 ↗ |
| Route | Intravenous | “an intravenous infusion, given over 10 minutes” NCT00807872 ↗ |